A large real world analysis presented at AHA 2025 suggests that adults with type 2 diabetes at moderate to high cardiovascular risk may experience fewer heart attacks, strokes, and deaths with low dose aspirin use, challenging the idea that primary prevention aspirin is always inappropriate.
Study Details
For the past decade, guidelines have steadily move…



